Hikma Pharmaceuticals (HIKL)

1,533.00p
   
  • Change Today:
    -0.24p
  • 52 Week High: 2,348.00
  • 52 Week Low: 1,505.00
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 88,369
  • Market Cap: £3,056.57m

HIKL Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CFO: Khalid Nabilsi
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: Deneen Vojta
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Laura Balan Balan
Senior Independent Director: Victoria Hull
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Overseas Listings: LSE:HIK
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,533.00p
Change Today -0.24p
% Change -1.54 %
52 Week High 2,348.00
52 Week Low 1,505.00
Volume 88,369
Shares Issued 199.39m
Market Cap £3,056.57m

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

HIKL Key Personnel

CFO Khalid Nabilsi

Top of Page